AMBARELLA, INC. (AMBA): what the price requires

At today's price, AMBARELLA, INC. (AMBA) is priced for today's economics sustained for ~18.9 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-19 · Source: https://boothcheck.com/report/AMBA

Headline

FieldValue
TickerAMBA
CompanyAMBARELLA, INC.
Current price$72.27/sh

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisrevenue-multiple
EV / sales paid7.8x
Steady-state operating margin assumed25.4%
Must persist for18.9y

The company earns no operating profit yet; the inversion runs on the revenue multiple and an assumed steady-state margin.

Solve inputs: computed at a 15% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~3.1 years.

Reconcile: at the x-ray's 9.3% required return this reads ~6.2 years; the models below use their own rates.

How unusual the bet is: elevated

ReferenceValue
vs own history+0.87σ
sustained it ~10 years at this level15%
implied end-window share0%

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset5.49x2expensive
Earnings11.43x1expensive
Relative1.56x2expensive
Growth1.02x3expensive

Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.2%); the inversion above states its own rate.

Per-Model Detail (n=8)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$15.624.63xyesFCF base $0.0B, growth 25% (input: historical growth), terminal g 4.0%, WACC 9.2%, 7yr projection
DCF Exit MultipleGrowth$0.00—noNegative/zero FCF or EBITDA — equity value floored at $0
Relative ValuationRelative$46.461.56xyesP/S fallback (negative EPS): Sector P/S 5.0x × TTM revenue — excluded from consensus
Simple DDMGrowth——no—
Two-Stage DDMGrowth——no—
Simple Excess ReturnAsset$13.895.20xyesBook value floor: BV/sh $13.89, ROE negative
Two-Stage Excess ReturnAsset$12.505.78xyesBook value with convergence: BV/sh $13.89, ROE converges to ke
Discounted Future Market CapGrowth$83.850.86xyesRev $0.4B, growth 30% (input: historical growth; tapered), Terminal P/S: 6.2x / 7.8x / 9.3x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$0.00—noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowth$70.781.02xyesMargin ramp: -17% → 25% over 7yr, rev growth 30% (input: historical growth; tapered)
Earnings Power ValueEarnings——no—
Residual IncomeAsset——no—
Graham NumberAsset——no—
EV/EBITDA RelativeRelative——no—
FCF YieldEarnings$6.3211.43xyesFCF $18.2M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings——no—
Ben Graham FormulaEarnings——no—
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative$46.461.56xyesRevenue $0.41B × sector P/S 5.0x
PEG Fair ValueRelative——no—
Earnings YieldEarnings——no—
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Net cash$277.8m
Share count CAGR (dilution)3.7%
Burning cashno

Operating profit is negative or near zero and the company has no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so years-to-repay cannot be computed honestly.

Operating profit is negative or near zero and there is no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so interest coverage cannot be computed honestly.

Bullet Takeaways

Bull Case

The gap between what the market is pricing and what the income statement shows is the whole debate, and the bull case argues the income statement is the lagging indicator. Today Ambarella reports a GAAP loss, with revenue of $390.7 million in fiscal 2026, up 37.2%. The market values it at a large multiple of that revenue, which only makes sense if you believe the business is early in a steep ramp rather than mature. The evidence says it is early. The company has reached 42 million edge-AI chips installed and $1 billion in cumulative edge-AI revenue, and edge-AI revenue grew 50% in the year. Those are scale milestones a pre-inflection business hits just before operating leverage shows up, and they are what the price is paying for, not the trailing loss.

The product position is the reason to believe the ramp continues. Ambarella derives, in the filing's words, "substantially all of our revenue from the sale of low power AI-based processing and video and image processing SoC solutions to IoT OEMs, IoT ODMs, automotive OEMs or Tier-1 automotive suppliers." Running AI inference at the edge, on the camera or in the car rather than in a data center, is a distinct engineering problem from training chips, and it rewards exactly the low-power video specialization Ambarella has built for years. The company is pushing its process technology forward, introducing third-generation 5-nanometer chips that drove fourth-quarter revenue and a 4-nanometer part expected to generate revenue the following year. New silicon at smaller geometries is how a chip company stays ahead of the price pressure that erodes older parts.

The financial setup gives the ramp room to play out. Ambarella holds about $278 million in net cash with no debt, so it is funding its own development without borrowing, and free cash flow has turned modestly positive even while the GAAP line shows a loss, which is the difference between a company investing through profitability and one burning toward a wall. The non-GAAP gross margin guidance of roughly 59% to 60% reflects the high-value, software-rich nature of the chips, and that margin is what eventually drops to the bottom line as revenue scales past the fixed cost of the engineering organization. A debt-free, cash-generative chip designer with a clear edge-AI franchise hitting billion-dollar scale milestones is the bull case, and it rests on the growth the market is already paying for being real.

Bear Case

The capital-allocation concern is the quiet problem, and it shows up as dilution. Ambarella's share count has been rising about 3.7% a year, driven by the stock it issues to employees, which the filing accounts for using "the Black-Scholes option pricing model to determine the fair value of shares to be issued" under its equity plans. For a company still posting a GAAP loss, stock compensation is how the engineering organization is paid, which means the cost of running the business is partly hidden below the operating line and partly passed to shareholders as a growing share count. Every year, the per-share value of the franchise has to grow faster than the share count just to stand still, and a company that is not yet GAAP-profitable is funding its own people by quietly handing them a larger slice of the company. The price embeds the growth turning to profit; the dilution is a tax on that profit before it arrives.

Competition is the second pressure, and it is severe for a small chip company. Ambarella warns that "increased competition could result in price pressure, reduced profitability and loss of market share," and that its competitors "range from large, international companies with greater resources," adding that it "face[s] intense competition and expect[s] competition to increase in the future." Edge AI is the most attractive growth area in semiconductors right now, which guarantees that far larger companies with deeper balance sheets are targeting the same automotive and IoT sockets. A company at under $400 million in revenue cannot outspend those rivals on research and development, and in chips the qualification cycle is long and expensive, so a design loss locks the company out of a platform for years.

The valuation is where the bear's caution becomes concrete. No method that values the demonstrated business reaches the price. The asset floor sits near book value around $14 a share, a free-cash-flow capitalization near $6, and even a forward sales-multiple read lands near $46, all below the $69.94 price (June 27, 2026). Only the methods that assume years of fast growth and a large margin ramp reach it, and they get there by projecting the operating margin from its current negative level toward the mid-twenties over a very long horizon. That is an enormous transformation, and the price assumes it happens. The balance sheet is healthy, so this is not a survival risk; it is a richly-priced-growth risk. The bear case is that the edge-AI story is real but the price has already paid for nearly two decades of flawless margin expansion, against intense competition and with ongoing dilution eating into whatever profit eventually appears.

Valuation

Ambarella is valued on its revenue and its growth, not its earnings, because there are no earnings to value: the company posts a GAAP loss. At $69.94 the price sits at a large multiple of the roughly $390 million in trailing revenue, and the bet embedded in that multiple is a long, steep ramp from loss to substantial profitability. The inversion makes the demand explicit: the price requires the operating margin to climb from its current negative level toward the mid-twenties percent, sustained over a horizon stretching to nearly two decades. That is not a near-term earnings story; it is a wager on the edge-AI franchise compounding for a very long time and converting to high-margin profit along the way.

The methods we use to triangulate split sharply along the profitability line. The static lenses that price the demonstrated business land far below the price: an asset floor near book value around $14, a free-cash-flow capitalization near $6 on the thin current cash generation. The forward-growth methods reach the price, with a discounted-future-market-cap read near $81 and a margin-trajectory model that ramps the operating margin from negative to the mid-twenties landing near $71. The pattern is the signature of a profitless growth chip company: only the methods that assume the ramp lands can justify the price, and the spread between them and the static methods is the entire premium. A forward sales-multiple read near $46 sits between, closer to the static side, which is a reminder that even crediting the revenue growth, the price asks for more than the multiple alone supports.

Solvency is a non-issue and a genuine support under the downside. Ambarella holds about $278 million in net cash with no debt, so it can fund its development internally for years without raising capital, and free cash flow has turned modestly positive, so it is not burning toward a financing crisis. The one balance-sheet-adjacent negative is the rising share count, up about 3.7% a year on stock compensation, which dilutes the per-share claim and is the price of paying an engineering team without GAAP profits. The decisive variable for the valuation is not the balance sheet; it is whether the edge-AI ramp delivers the margin the price assumes, against intense competition, over a horizon long enough that small deviations compound into large differences in outcome.

Catalysts

Ambarella closed fiscal 2026 with its growth reaccelerating around edge AI. Full-year revenue rose 37.2% to $390.7 million, and fourth-quarter revenue grew 20.1% to $100.9 million, ahead of expectations, with the strength concentrated in the IoT and automotive segments. IoT revenue grew nearly 50% year over year on increased adoption of edge AI, and the company highlighted reaching 42 million edge-AI chips installed and $1 billion in cumulative edge-AI revenue, both scale markers for the franchise.

The product and guidance markers point to continued momentum. The company's third-generation 5-nanometer CV75 and CV72 AI chips contributed meaningfully to the fourth quarter, and a 4-nanometer part is expected to generate revenue in the following fiscal year, extending the product roadmap. For the first quarter of fiscal 2027, the company guided revenue of $97 million to $103 million with a non-GAAP gross margin of about 59% to 60.5%. The next prints are the test of whether the edge-AI growth rate holds and whether the operating loss narrows as revenue scales, since the price assumes the ramp continues for years. New design wins moving into production, not the quarterly revenue itself, are the leading indicator to watch.

Peer Cohorts (Per Segment, With Filing Citations)

Ambarella (consolidated) (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

FY2026 earnings release · FY2026 earnings call · Q1 FY2027 guidance

View the full interactive AMBA report on boothcheck